- Home
- BTAI vs EFOI Comparison
BTAI vs EFOI Comparison
Compare BTAI & EFOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTAI
- EFOI
- Stock Information
- Founded
- BTAI 2017
- EFOI 1985
- Country
- BTAI United States
- EFOI United States
- Employees
- BTAI N/A
- EFOI N/A
- Industry
- BTAI Biotechnology: Pharmaceutical Preparations
- EFOI Building Products
- Sector
- BTAI Health Care
- EFOI Consumer Discretionary
- Exchange
- BTAI Nasdaq
- EFOI Nasdaq
- Market Cap
- BTAI 8.3M
- EFOI 12.1M
- IPO Year
- BTAI 2018
- EFOI 1994
- Fundamental
- Price
- BTAI $1.86
- EFOI $2.40
- Analyst Decision
- BTAI Buy
- EFOI
- Analyst Count
- BTAI 5
- EFOI 0
- Target Price
- BTAI $34.60
- EFOI N/A
- AVG Volume (30 Days)
- BTAI 295.5K
- EFOI 21.9K
- Earning Date
- BTAI 08-05-2025
- EFOI 08-12-2025
- Dividend Yield
- BTAI N/A
- EFOI N/A
- EPS Growth
- BTAI N/A
- EFOI N/A
- EPS
- BTAI N/A
- EFOI N/A
- Revenue
- BTAI $1,852,000.00
- EFOI $4,643,000.00
- Revenue This Year
- BTAI $5.03
- EFOI N/A
- Revenue Next Year
- BTAI $291.01
- EFOI N/A
- P/E Ratio
- BTAI N/A
- EFOI N/A
- Revenue Growth
- BTAI 5.47
- EFOI N/A
- 52 Week Low
- BTAI $1.17
- EFOI $1.14
- 52 Week High
- BTAI $21.92
- EFOI $2.95
- Technical
- Relative Strength Index (RSI)
- BTAI 56.60
- EFOI 61.50
- Support Level
- BTAI $1.69
- EFOI $1.64
- Resistance Level
- BTAI $2.08
- EFOI $2.48
- Average True Range (ATR)
- BTAI 0.21
- EFOI 0.20
- MACD
- BTAI 0.02
- EFOI 0.05
- Stochastic Oscillator
- BTAI 57.89
- EFOI 81.13
About BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About EFOI Energy Focus Inc.
Energy Focus Inc engages in the design, development, manufacturing, marketing, and sale of energy-efficient lighting systems and controls. The company serves the military maritime market and general commercial markets. Its product offerings include Military maritime LED lighting products such as military intelligible, globe lights, berth lights, and military fixtures and Commercial products such as LED fixtures and panels, LED down-lights, LED dock lights, and LED retrofit kits. Geographically, it operates in the United States and other countries. Its products include commercial products and MMM products. The company generates a majority of its sales from Military maritime products in the United States.